Phase I study of plerixafor and bevacizumab in recurrent high-grade glioma.
Katrina H. Smith
No relevant relationships to disclose
Eudocia Quant Lee
Consultant or Advisory Role - Roche/Genentech
Alona Muzikansky
No relevant relationships to disclose
Elizabeth Robins Gerstner
No relevant relationships to disclose
Dan G. Duda
Consultant or Advisory Role - HEXAL / Sandoz
David A. Reardon
Consultant or Advisory Role - Roche/Genentech
Honoraria - Roche/Genentech
Lakshmi Nayak
No relevant relationships to disclose
Andrew David Norden
No relevant relationships to disclose
Lisa M. Doherty
No relevant relationships to disclose
Jennifer Rifenburg
No relevant relationships to disclose
Debra C. LaFrankie
No relevant relationships to disclose
Sandra Ruland
No relevant relationships to disclose
Julee Pulverenti
No relevant relationships to disclose
Deirdre Stokes
No relevant relationships to disclose
Priscilla Lam
No relevant relationships to disclose
Christine Sceppa McCluskey
No relevant relationships to disclose
Sarah C. Gaffey
No relevant relationships to disclose
Tracy Batchelor
Consultant or Advisory Role - Kirin Pharmaceuticals; Merck; Novartis; Proximagen; Roche
Research Funding - AstraZeneca; Millennium; Pfizer
Rakesh K. Jain
Research Funding - MedImmune; Roche
Patrick Y. Wen
Consultant or Advisory Role - Roche/Genentech
Research Funding - Roche/Genentech; Sanofi/Genzyme